298 related articles for article (PubMed ID: 7845667)
41. EWS fli-1 antisense nanocapsules inhibits ewing sarcoma-related tumor in mice.
Lambert G; Bertrand JR; Fattal E; Subra F; Pinto-Alphandary H; Malvy C; Auclair C; Couvreur P
Biochem Biophys Res Commun; 2000 Dec; 279(2):401-6. PubMed ID: 11118299
[TBL] [Abstract][Full Text] [Related]
42. Oncogenic TLS/ERG and EWS/Fli-1 fusion proteins inhibit RNA splicing mediated by YB-1 protein.
Chansky HA; Hu M; Hickstein DD; Yang L
Cancer Res; 2001 May; 61(9):3586-90. PubMed ID: 11325824
[TBL] [Abstract][Full Text] [Related]
43. Identification of target genes for the Ewing's sarcoma EWS/FLI fusion protein by representational difference analysis.
Braun BS; Frieden R; Lessnick SL; May WA; Denny CT
Mol Cell Biol; 1995 Aug; 15(8):4623-30. PubMed ID: 7623854
[TBL] [Abstract][Full Text] [Related]
44. EWS-FLI1 target genes recovered from Ewing's sarcoma chromatin.
Siligan C; Ban J; Bachmaier R; Spahn L; Kreppel M; Schaefer KL; Poremba C; Aryee DN; Kovar H
Oncogene; 2005 Apr; 24(15):2512-24. PubMed ID: 15735734
[TBL] [Abstract][Full Text] [Related]
45. Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma.
Crozat A; Aman P; Mandahl N; Ron D
Nature; 1993 Jun; 363(6430):640-4. PubMed ID: 8510758
[TBL] [Abstract][Full Text] [Related]
46. Promoters containing ATF-binding sites are de-regulated in cells that express the EWS/ATF1 oncogene.
Brown AD; Lopez-Terrada D; Denny C; Lee KA
Oncogene; 1995 May; 10(9):1749-56. PubMed ID: 7753552
[TBL] [Abstract][Full Text] [Related]
47. A link between basic fibroblast growth factor (bFGF) and EWS/FLI-1 in Ewing's sarcoma cells.
Girnita L; Girnita A; Wang M; Meis-Kindblom JM; Kindblom LG; Larsson O
Oncogene; 2000 Aug; 19(37):4298-301. PubMed ID: 10980604
[TBL] [Abstract][Full Text] [Related]
48. EWS/ETS fusion genes induce epithelial and neuroectodermal differentiation in NIH 3T3 fibroblasts.
Teitell MA; Thompson AD; Sorensen PH; Shimada H; Triche TJ; Denny CT
Lab Invest; 1999 Dec; 79(12):1535-43. PubMed ID: 10616204
[TBL] [Abstract][Full Text] [Related]
49. Preferential down-regulation of phospholipase C-beta in Ewing's sarcoma cells transfected with antisense EWS-Fli-1.
Dohjima T; Ohno T; Banno Y; Nozawa Y; Wen-yi Y; Shimizu K
Br J Cancer; 2000 Jan; 82(1):16-9. PubMed ID: 10638960
[TBL] [Abstract][Full Text] [Related]
50. Stimulation of Oct-4 activity by Ewing's sarcoma protein.
Lee J; Rhee BK; Bae GY; Han YM; Kim J
Stem Cells; 2005; 23(6):738-51. PubMed ID: 15917470
[TBL] [Abstract][Full Text] [Related]
51. The EWS-Oct-4 fusion gene encodes a transforming gene.
Lee J; Kim JY; Kang IY; Kim HK; Han YM; Kim J
Biochem J; 2007 Sep; 406(3):519-26. PubMed ID: 17564582
[TBL] [Abstract][Full Text] [Related]
52. DAX1, a direct target of EWS/FLI1 oncoprotein, is a principal regulator of cell-cycle progression in Ewing's tumor cells.
García-Aragoncillo E; Carrillo J; Lalli E; Agra N; Gómez-López G; Pestaña A; Alonso J
Oncogene; 2008 Oct; 27(46):6034-43. PubMed ID: 18591936
[TBL] [Abstract][Full Text] [Related]
53. Cloning and chromosome localization of the mouse Ews gene.
Plougastel B; Mattei MG; Thomas G; Delattre O
Genomics; 1994 Sep; 23(1):278-81. PubMed ID: 7829090
[TBL] [Abstract][Full Text] [Related]
54. Targeting of EWS/FLI-1 by RNA interference attenuates the tumor phenotype of Ewing's sarcoma cells in vitro.
Chansky HA; Barahmand-Pour F; Mei Q; Kahn-Farooqi W; Zielinska-Kwiatkowska A; Blackburn M; Chansky K; Conrad EU; Bruckner JD; Greenlee TK; Yang L
J Orthop Res; 2004 Jul; 22(4):910-7. PubMed ID: 15183454
[TBL] [Abstract][Full Text] [Related]
55. SRE elements are binding sites for the fusion protein EWS-FLI-1.
Magnaghi-Jaulin L; Masutani H; Robin P; Lipinski M; Harel-Bellan A
Nucleic Acids Res; 1996 Mar; 24(6):1052-8. PubMed ID: 8604338
[TBL] [Abstract][Full Text] [Related]
56. The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1.
May WA; Lessnick SL; Braun BS; Klemsz M; Lewis BC; Lunsford LB; Hromas R; Denny CT
Mol Cell Biol; 1993 Dec; 13(12):7393-8. PubMed ID: 8246959
[TBL] [Abstract][Full Text] [Related]
57. Transformation induced by Ewing's sarcoma associated EWS/FLI-1 is suppressed by KRAB/FLI-1.
Chan D; Wilson TJ; Xu D; Cowdery HE; Sanij E; Hertzog PJ; Kola I
Br J Cancer; 2003 Jan; 88(1):137-45. PubMed ID: 12556973
[TBL] [Abstract][Full Text] [Related]
58. The EWS protein is dispensable for Ewing tumor growth.
Kovar H; Jug G; Hattinger C; Spahn L; Aryee DN; Ambros PF; Zoubek A; Gadner H
Cancer Res; 2001 Aug; 61(16):5992-7. PubMed ID: 11507040
[TBL] [Abstract][Full Text] [Related]
59. Development of Ewing's sarcoma from primary bone marrow-derived mesenchymal progenitor cells.
Riggi N; Cironi L; Provero P; Suvà ML; Kaloulis K; Garcia-Echeverria C; Hoffmann F; Trumpp A; Stamenkovic I
Cancer Res; 2005 Dec; 65(24):11459-68. PubMed ID: 16357154
[TBL] [Abstract][Full Text] [Related]
60. Ewing's sarcoma fusion protein, EWS/Fli-1 and Fli-1 protein induce PLD2 but not PLD1 gene expression by binding to an ETS domain of 5' promoter.
Kikuchi R; Murakami M; Sobue S; Iwasaki T; Hagiwara K; Takagi A; Kojima T; Asano H; Suzuki M; Banno Y; Nozawa Y; Murate T
Oncogene; 2007 Mar; 26(12):1802-10. PubMed ID: 16964281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
